IO Biotech Inc (NASDAQ: IOBT) on Friday, soared 10.80% from the previous trading day, before settling in for the closing price of $0.44. Within the past 52 weeks, IOBT’s price has moved between $0.32 and $2.79.
A company in the Healthcare sector has dropped its sales by -27.25% annually for the last half of the decade. The company achieved an average annual earnings per share of 13.79%. With a float of $49.27 million, this company’s outstanding shares have now reached $65.88 million.
IO Biotech Inc (IOBT) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of IO Biotech Inc is 25.21%, while institutional ownership is 20.21%. The most recent insider transaction that took place on May 30 ’25, was worth 20,884. In this transaction Director of this company bought 15,000 shares at a rate of $1.39, taking the stock ownership to the 15,000 shares. Before that another transaction happened on Dec 23 ’24, when Company’s Chief Medical Officer bought 31,350 for $0.85, making the entire transaction worth $26,553. This insider now owns 31,350 shares in total.
IO Biotech Inc (IOBT) Latest Financial update
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.34 earnings per share (EPS) for the period topping the consensus outlook (set at -0.35) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 13.79% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 25.69% during the next five years compared to -27.25% drop over the previous five years of trading.
IO Biotech Inc (NASDAQ: IOBT) Trading Performance Indicators
IO Biotech Inc (IOBT) is currently performing well based on its current performance indicators. A quick ratio of 1.96 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.58, a number that is poised to hit -0.31 in the next quarter and is forecasted to reach -0.54 in one year’s time.
Technical Analysis of IO Biotech Inc (IOBT)
Let’s dig in a bit further. During the last 5-days, its volume was 13.88 million. That was better than the volume of 1.57 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 7.49%.
During the past 100 days, IO Biotech Inc’s (IOBT) raw stochastic average was set at 6.43%, which indicates a significant decrease from 10.53% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1005 in the past 14 days, which was lower than the 0.1728 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.6576, while its 200-day Moving Average is $1.2434. However, in the short run, IO Biotech Inc’s stock first resistance to watch stands at $0.5080. Second resistance stands at $0.5340. The third major resistance level sits at $0.5680. If the price goes on to break the first support level at $0.4480, it is likely to go to the next support level at $0.4140. The third support level lies at $0.3880 if the price breaches the second support level.
